A phase III study of Æ-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non- small cell lung cancer (NSCLC) (NCI T99–0046, RTOG 02–70, MDA 99–303)

Abstract

7527

Lu C; Lee JJ; Komaki R; Herbst RS; Evans WK; Choy H; Desjardins P; Esparaz BT; Truong M; Fisch MJ

Journal of Clinical Oncology, Vol. 25, No. 18_suppl, pp. 7527–7527

American Society of Clinical Oncology (ASCO)

June 20, 2007

10.1200/jco.2007.25.18_suppl.7527

0732-183X

William Evans